Poster Abstract Session:
129. All Things Microbiome
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID, Investigative ID

Presentations:
750
Ecological Effect of Ceftaroline/Avibactam on the Normal Human Intestinal Microbiota 
Carl Erik Nord, PhD, MD, FIDSA ; Mamun-Ur Rashid, MD, PhD ; Staffan Rosenborg, MD, PhD ; Georgios Panagiotidis, MD, PhD ; Karin Söderberg Löfdal, MD, PhD ; Andrej Weintraub, PhD
751
Using propodium monoazide sequencing (PMA-seq) to develop data-driven best practices in fecal microbiota transplantations
Nathaniel Chu, BS ; Mark Smith, PhD ; Allison Perrotta, BS ; Zain Kassam, MD, MPH ; Eric Alm, PhD
Posters
  • poster_draftOC012015_768px.pdf (739.6 kB)
  • 752
    Exploratory analysis of the plasma metagenome reveals no difference between individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and healthy controls
    Ruth Miller, DPhil ; Jennifer Gardy, PhD ; Shoshana Parker, BSc ; Theodore Steiner, MD ; Vincent Montoya, MSc ; Patrick Tang, M.D., Ph.D., FRCPC ; David M. Patrick, MD, MHSc, FRCPC
    Posters
  • 752_IDWPOSTER.pdf (8.0 MB)
  • 753
    Breastfeeding influences establishment and development of the infant microbiome
    Pia S. Pannaraj, MD, MPH ; Fan Li, PhD ; Chiara Cerini, MD ; Jeffery Bender, MD ; Kyle Bittinger, PhD ; Aubrey Bailey, PhD ; Adrienne Rollie, MS ; Helty Adisetiyo, PhD ; Chintda Santiskulvong, PhD ; Frederic Bushman, PHD ; John Sleasman, MD ; Grace Aldrovandi, MD, PhD
    Posters
  • USBMK_IDweekPoster.pdf (884.7 kB)
  • 754
    Expanded Enteric Virome and Altered Bacterial Microbiome in AIDS
    Cynthia Monaco, M.D., Ph.D. ; David Gootenberg, B.A. ; Guoyan Zhao, Ph.D. ; Efrem Lim, Ph.D. ; Musie Ghebremichael, Ph.D. ; Megan Baldridge, M.D., Ph.D. ; Craig Wilen, M.D., Ph.D. ; Scott Handley, Ph.D. ; Meaghan Flagg, B.S. ; Mark Siedner, M.D. M.P.H. ; Jason Norman, Ph.D. ; Brian Keller, M.D., Ph.D. ; Alexander Lankowski, M.A. ; David Wang, Ph.D. ; Douglas Kwon, M.D., Ph.D. ; Herbert Virgin, M.D., Ph.D.
    755
    Comparison of Stool versus Rectal Swab Samples from Long-Term Acute Care Hospital (LTACH) Patients for Microbiota Analysis
    Christine M. Bassis, PhD ; Anna Seekatz, PhD ; Nicholas M. Moore, MS ; Karen Lolans, BS ; Robert a. Weinstein, MD, FIDSA, FSHEA ; Vincent B. Young, MD/PhD, FIDSA ; Mary K. Hayden, MD, FIDSA, FSHEA ; For the CDC Prevention Epicenters Program, .
    756
    Low Lactobacillus spp. Abundance Characterizes the Fecal Microbiome of Patients Acquiring Multidrug-Resistant Organisms During Hospitalization
    Rafael Araos Bralic, MD MMSc ; Albert K. Tai, PhD ; Graham M Snyder, MD, SM ; Martin Blaser, MD, FIDSA ; Erika D'agata, MD, MPH
    757
    Vancomycin-resistant enterococcal (VRE) titers diminish among patients with recurrent Clostridium difficile infection after administration of SER-109, a novel microbiome agent
    Mary-Jane Lombardo, PhD ; Marin Vulic, PhD ; Toshi Ohsumi, PhD ; David Cook, PhD ; Matthew Henn, PhD ; Colleen Kraft, MD ; Sahil Khanna, MBBS, MS ; Darrell Pardi, MD, MS ; Elizabeth Hohmann, MD, FIDSA
    760
    DAV132, an Adsorbent-Based Product, Protects the Gut Microbiome and Prevents Clostridium difficile Infections during Moxifloxacin Treatments
    Jean De Gunzburg, PhD ; Amine Ghozlane, PhD ; Annie Ducher, MD ; Xavier Duval, MD, PhD ; Etienne Ruppé, PharmD, PhD ; Mark Pulse, MS ; Caroline Chilton, PhD ; Laurence Armand-Lefevre, PharmD, PhD ; Elisabeth Chachaty, PharmD, PhD ; Sakina Sayah-Jeanne, PhD ; Joël Doré, PhD ; Emmanuelle Le Chatelier, PhD ; Florence Levenez, BS ; Sean Kennedy, PhD ; Nicolas Pons, PhD ; William Weiss, MS ; Mark Wilcox, MD ; France Mentré, MD, PhD ; Antoine Andremont, MD, PhD ; Stanislav Dusko Ehrlich, PhD
    761
    Impact of ascending dosages of cadazolid or vancomycin on the intestinal microbiome during treatment of C. difficile infection
    Kaiyu Wu, PhD ; Heidi O'grady, PhD ; Matthew Workentine, PhD ; Karen Poon, PhD ; Brendan Byrne, RN ; Joseph Kim, MD ; Thomas Louie, MD
    762
    Autologous fecal microbiota transplantation as a strategy to prevent colonization with multi-drug resistant organisms following antimicrobial therapy
    Christopher Bulow, BA ; Alaric D'souza, BS ; Tiffany Hink, BS ; Meghan Wallace, BS ; Kimberly Reske, MPH ; Xiaoqing Sun, MS ; Jennie H. Kwon, D.O. ; Carey-Ann D. Burnham, PhD ; Gautam Dantas, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.